title: Renal myelofibrosis: an unusual cause of renal impairment.
authors.affiliation: Departments of Nephrology, Haematology and Histopathology, University College Hospitals, London, UK.
authors.forename: N
authors.initials: N
authors.lastname: Woodward
authors.forename: P
authors.initials: P
authors.lastname: Ancliffe
authors.forename: M H
authors.initials: MH
authors.lastname: Griffiths
authors.forename: S
authors.initials: S
authors.lastname: Cohen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003561:Cytarabine / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006411:Hematopoiesis, Extramedullary; D006801:Humans; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000209:etiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000150:complications* / Q000188:drug therapy; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine